Femme et Homme
- | Pays :
- Sweden
- Canada
- United Kingdom
- ...
- | Organes : -
- | Spécialités : -
Extrait
Primary objective: => To describe the Seroprotection rate (SPR) at least 2 years following completion of a primary series with an Hepatitis B vaccine and 1 month following a challenge dose of HBVaxPro. Secondary Objective: => To describe the safety and tolerability of a challenge dose of HBVaxPro in adults ≥50 years of age.
Critère d'inclusion
- Hepatitis B